{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T15:29:44Z","timestamp":1760887784285},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1991,10,1]],"date-time":"1991-10-01T00:00:00Z","timestamp":686275200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biotherapy"],"published-print":{"date-parts":[[1991,10]]},"DOI":"10.1007\/bf02221331","type":"journal-article","created":{"date-parts":[[2005,10,6]],"date-time":"2005-10-06T14:41:29Z","timestamp":1128609689000},"page":"373-379","source":"Crossref","is-referenced-by-count":4,"title":["A possible clinical application of multicytokine-producing cytotoxic mononuclear cell (MCCM) therapy"],"prefix":"10.1007","volume":"3","author":[{"given":"Mitsuo","family":"Katano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiro","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsunari","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeharau","family":"Hisatsugu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Katsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisao","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyonobu","family":"Ikezaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Tabuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumio","family":"Nagumo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jutaro","family":"Tadano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02221331_CR1","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1084\/jem.155.6.1823","volume":"155","author":"EE Grimm","year":"1982","unstructured":"Grimm EE, Mazumder A, Zhang HZ, Rosemberg SA. The lymphokine-activated killer cell phenomenon: lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 1982; 155: 1823\u201341.","journal-title":"J Exp Med"},{"key":"BF02221331_CR2","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1001\/jama.1986.03380220083027","volume":"256","author":"MT Lotze","year":"1986","unstructured":"Lotze MT, Chang AE, Seipp CA, Simpson C, Vetto JT, Rosemberg SA. High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer: responses, treatment-related morbidity, and histologic findings. JAMA 1986; 256: 3117\u201324.","journal-title":"JAMA"},{"key":"BF02221331_CR3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJM198704093161501","volume":"316","author":"SA Rosemberg","year":"1987","unstructured":"Rosemberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitmann S, Linehan WM, Robertson CN, Lee RE, Rubin JT, Seipp CA, Simpson CG, White DE. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 1987; 316: 889\u201397.","journal-title":"N Engl J Med"},{"key":"BF02221331_CR4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0167-5699(88)91261-3","volume":"9","author":"SA Rosemberg","year":"1988","unstructured":"Rosemberg SA. Immunotherapy of cancer using interleukin 2. Immunology Today 1988; 9: 58\u201362.","journal-title":"Immunology Today"},{"key":"BF02221331_CR5","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.4049\/jimmunol.125.4.1487","volume":"125","author":"MT Lotze","year":"1980","unstructured":"Lotze MT, Line BR, Mathisen DJ, Rosenberg SA. Thein vivo distribution of autologous human and murine lymphoid cells grown in T cell growth factor (TCGF): implications of the adoptive immunotherapy of tumors. J Immunol 1980; 125: 1487\u201393.","journal-title":"J Immunol"},{"key":"BF02221331_CR6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/302305a0","volume":"302","author":"T Taniguchi","year":"1983","unstructured":"Taniguchi T, Matsui H, Fujita T, Takioba C, Kashmer N, Yoshimoto R, Hamuro J. Structure and expression of a cloned cDNA for human interleukin-2. Nature 1983; 302: 305\u20139.","journal-title":"Nature"},{"key":"BF02221331_CR7","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM198411013111803","volume":"311","author":"JR Quesada","year":"1984","unstructured":"Quesada JR, Reuben J, Manning JT, Hersh EM, Gutterman JE. Alpha interferon for induction of remission in hairy-cell leukemia. N Engl J Med 1984; 311: 1148\u201352.","journal-title":"N Engl J Med"},{"key":"BF02221331_CR8","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM198704093161502","volume":"316","author":"HW West","year":"1987","unstructured":"West HW, Tauer KW, Yannelli JR, Marshall GD, Orr DW, Thurman GB, Oldham RK. Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer. N Engl J Med 1987; 316: 898\u2013905.","journal-title":"N Engl J Med"},{"key":"BF02221331_CR9","first-page":"1883","volume":"139","author":"RS Cotran","year":"1987","unstructured":"Cotran RS, Pober JS, Gimbrone MA, Springer TA, Wiebke EA, Gaspari AA, Rosemberg SA, Lotze MT. Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular syndrome. J Immunol 1987; 139: 1883\u20138.","journal-title":"J Immunol"},{"key":"BF02221331_CR10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ijc.2910320107","volume":"32","author":"A Uchida","year":"1983","unstructured":"Uchida A, Mickshe M. Lysis of fresh human tumor cells by autologous large granular lymphocytes from peripheral blood and pleural effusions. Int J Cancer 1983; 32: 37\u201344.","journal-title":"Int J Cancer"},{"key":"BF02221331_CR11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000233510","volume":"74","author":"M Ley De","year":"1984","unstructured":"De Ley M, Claeys H. Streptococcal preparation OK-432induced interferon in human luekocytes: purification and characterization. Int Arch Allergy Appl Immunol 1984; 74: 21\u20138.","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"BF02221331_CR12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0192-0561(85)90035-9","volume":"7","author":"O Ichimura","year":"1985","unstructured":"Ichimura O, Suzuki S, Saito M, Sugawara Y, Ishida N. Augmentation of interleukin 1 and interleukin 2 production by OK-432. Int J Immunopharmacol 1985; 7: 263\u201370.","journal-title":"Int J Immunopharmacol"},{"key":"BF02221331_CR13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0162-3109(86)90027-5","volume":"11","author":"A Yamamoto","year":"1986","unstructured":"Yamamoto A, Nagamuta M, Usami H, Sugawara Y, Watanabe N, Niitsu Y, Urushizaki I. Release of tumor necrosis factor (TNF) into mouse peritoneal fluid by OK-432, a streptococcal preparation. Immunopharmacology 1986; 11: 79\u201386.","journal-title":"Immunopharmacology"},{"key":"BF02221331_CR14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF00205440","volume":"27","author":"M Katano","year":"1988","unstructured":"Katano M, Yamamoto H, Mizoguchi T, Hisatsugu T. Induction of tumor growth inhibitory factor (TGIF) in human mononuclear cells by OK-432, a streptococcal preparation. Cancer Immunol Immunother 1988; 27: 198\u2013204.","journal-title":"Cancer Immunol Immunother"},{"key":"BF02221331_CR15","first-page":"3","volume-title":"OK-432","author":"T Hoshino","year":"1984","unstructured":"Hoshino T, Uchida A. OK-432 (picibanil): property, action and clinical effectiveness. In: Hoshino T, ed. OK-432. Amsterdam: Excerpta Medica, 1984: 3\u201321."},{"key":"BF02221331_CR16","first-page":"357","volume":"93","author":"M Katano","year":"1983","unstructured":"Katano M, Torisu M. New approach to the management of malignant ascites by a streptococcal preparation, OK432 (III) OK-432-induced intraperitoneal inflammatory cells-mediated tumor cell destruction in malignant ascites. Surgery 1983; 93: 357\u201364.","journal-title":"Surgery"},{"key":"BF02221331_CR17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0022-1759(85)90040-7","volume":"77","author":"E Tanaka","year":"1985","unstructured":"Tanaka E, Imai M, Usuda S, Tachibana K, Okamoto H, Ohike Y, Nakamura T, Miyakawa Y, Mayumi M. A two-site sandowich radioimmunoassay of human gamma interferon with monoclonal antibodies. J Immunol Methods 1985; 77: 275\u201382.","journal-title":"J Immunol Methods"},{"key":"BF02221331_CR18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1126\/science.560061","volume":"197","author":"AW Hamburger","year":"1977","unstructured":"Hamburger AW, Salmon SE. Primary bioassay of human tumor stem cells. Science 1977; 197: 461\u20133.","journal-title":"Science"},{"key":"BF02221331_CR19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1349-7006.1990.tb02628.x","volume":"81","author":"N Tanigawa","year":"1990","unstructured":"Tanigawa N, Morimoto H. Colony-forming ability in vitro and clonology of colorectal cancer. Jpn J Cancer Res 1990; 81: 687\u201391.","journal-title":"Jpn J Cancer Res"},{"key":"BF02221331_CR20","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1084\/jem.155.6.1823","volume":"155","author":"EA Grimm","year":"1982","unstructured":"Grimm, EA, Mazumder HZ, Rosenberg SA. Lymphokine activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin-2 activated autologous human perihperal blood lymphocytes. J Exp Med 1982; 155: 1823\u201340.","journal-title":"J Exp Med"},{"key":"BF02221331_CR21","first-page":"75","volume-title":"OK-432","author":"A Uchida","year":"1984","unstructured":"Uchida A, Yanagawa E, Micksche M.In vivo andin vitro augmentation of natural killing and auto-tumor killing activity by OK-432. In: Hoshino T, ed. OK-432. Amsterdam: Excerpta Medica, 1984: 75\u201394."},{"key":"BF02221331_CR22","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.4049\/jimmunol.140.8.2621","volume":"140","author":"M Steffen","year":"1988","unstructured":"Steffen M, Ottomann OG, Moore MAS. Simultaneous production of tumor necrosis factor-alpha and lymphotoxin by normal T cells after induction with IL-2 and anti-T3. J Immunol 1988; 140: 2621\u20134.","journal-title":"J Immunol"},{"key":"BF02221331_CR23","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.4049\/jimmunol.142.6.2133","volume":"142","author":"AS-F Chong","year":"1989","unstructured":"Chong AS-F, Scuderi P, Grimes WJ, Hersh EM. Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor. J Immunol 1989; 142: 2133\u20139.","journal-title":"J Immunol"},{"key":"BF02221331_CR24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF01789178","volume":"31","author":"AS-F Chong","year":"1990","unstructured":"Chong AS-F, Ybarrondo B, Grimes WJ, Hersh EM, Scuderi P. Phenotypic analyses of lymphokine-activated killer cells that release interferon and tumor necrosis factor. Cancer Immunol Immunother 1990; 31: 255\u20139.","journal-title":"Cancer Immunol Immunother"},{"key":"BF02221331_CR25","first-page":"1549","volume":"4","author":"E Kubota","year":"1990","unstructured":"Kubota E, Katano M, Kurokawa H, Imamura H, Yamamoto H, Katsuki T. Induction of anti-tumor activity from the streptococcal preparation OK-432-stimulated human peripheral blood mononuclear cells. Biotherapy 1990; 4: 1549\u201354, summary in English.","journal-title":"Biotherapy"},{"key":"BF02221331_CR26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF02172074","volume":"2","author":"M Katano","year":"1990","unstructured":"Katano M, Yamamoto H, Nakamura M, Matsuo T, Hisatsugu T. Synergistic effects of TGIF and interferony (IFN-\u03b3) on tumor cell growth. Biotherapy 1990; 2: 33\u201340.","journal-title":"Biotherapy"},{"key":"BF02221331_CR27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF02470717","volume":"20","author":"M Katano","year":"1990","unstructured":"Katano M, Mizoguchi T, Yamamoto H, Nakamura M, Matsuo T, Hisatsugu T, Kisu T, Yamaoka K, Tokunaga O. The antitumor effects of locally injecting human peripheral blood mononuclear cells treated with OK-432 into the tumor site: the possible role of a tumor growth inhibitory factor (TGIF). Jpn J Surg 1990; 20: 76\u201382.","journal-title":"Jpn J Surg"}],"container-title":["Biotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02221331.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02221331\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02221331","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:31:18Z","timestamp":1683246678000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02221331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,10]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1991,10]]}},"alternative-id":["BF02221331"],"URL":"https:\/\/doi.org\/10.1007\/bf02221331","relation":{},"ISSN":["0921-299X","1573-8280"],"issn-type":[{"value":"0921-299X","type":"print"},{"value":"1573-8280","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,10]]}}}